Celecoxib Window of Opportunity Trial to Assess Tumor and Stroma Responses
Status: Withdrawn prior to enrolment
Phase of Trial: Phase II
Latest Information Update: 19 Nov 2019
Price : $35 *
At a glance
- Drugs Celecoxib (Primary)
- Indications Breast cancer; Carcinoma
- Focus Pharmacodynamics
- 11 Oct 2018 Status changed from recruiting to withdrawn prior to enrolment due to slow accrual.
- 31 Aug 2018 Biomarkers information updated
- 12 Dec 2017 Status changed from not yet recruiting to recruiting.